| | Mental Health | Depression
Understanding Depression: Symptoms, Causes, Diagnosis & Treatment
Major Depressive Disorder (MDD) is a common, serious medical illness affecting how you feel, think, and act. It is not a weakness, character flaw, or infectious disease. It involves biological, psychological, and social factors.
Core Symptoms (DSM-5: ≥5 for ≥2 weeks, including #1 or #2)
- Depressed mood most of the day, nearly every day (or irritability in adolescents).
- Markedly diminished interest/pleasure in all/most activities (anhedonia).
- Significant weight loss/gain or appetite change.
- Insomnia or hypersomnia.
- Psychomotor agitation or retardation (observable).
- Fatigue or loss of energy.
- Feelings of worthlessness or excessive/inappropriate guilt.
- Diminished ability to think, concentrate, or make decisions.
- Recurrent thoughts of death, suicidal ideation, plan, or attempt.
Contributing Factors
- Biological: Genetics (heritability ~40%), neurotransmitter dysregulation (serotonin, norepinephrine, dopamine), HPA axis hyperactivity, neuroinflammation, hippocampal atrophy.
- Psychological: Negative cognitive schemas, rumination, low self-esteem, trauma history, poor coping.
- Social/Environmental: Chronic stress, loss, isolation, poverty, abuse, medical illness, medication side effects, substance use.
Diagnosis
- Clinical interview (psychiatric/primary care) — no lab test confirms MDD.
- Rule out: Thyroid disease, B12/folate deficiency, anemia, medication effects, substance use, bipolar disorder, adjustment disorder, grief.
- Screening tools: PHQ-9 (9-item), Beck Depression Inventory (BDI-II).
Evidence-Based Treatments
| Modality | Examples | Indications |
|---|---|---|
| Psychotherapy | CBT, IPT, Behavioral Activation, ACT, MBCT, Psychodynamic | First-line for mild-moderate; combined with meds for moderate-severe |
| Antidepressants | SSRIs (first-line), SNRIs, bupropion, mirtazapine, vortioxetine, TCAs, MAOIs | Moderate-severe; patient preference; partial response to therapy |
| Brain Stimulation | ECT (gold standard for severe/refractory), TMS, VNS, DBS | Treatment-resistant, psychotic depression, catatonia, urgent need |
| Lifestyle & Adjunctive | Exercise (aerobic 150 min/wk), sleep hygiene, omega-3, folate (L-methylfolate), light therapy (seasonal), mindfulness | Augmentation; mild cases; relapse prevention |
Key Messages
- Depression is treatable. 70–80% respond to first-line treatment.
- Early intervention improves outcomes.
- Suicide risk: Ask directly. If imminent danger: 988 (US), ER, crisis line.
- Maintenance treatment (6–12+ months after remission) prevents relapse.
- Comorbidities: Anxiety, substance use, chronic pain, medical illness — treat concurrently.
If you or someone you know is struggling, help is available. Start with a primary care doctor, therapist, or call/text 988 (US Suicide & Crisis Lifeline).
Depression - Related Articles
- 10 Behavioral Traits That Reduce Depression Risk and Build Resilience
- Supporting a Depressed Spouse: A Guide for Partners
- Finding Support: A Guide to Bereavement Support Groups
- Accountant Salaries During the Great Depression: Historical Context
- Conquer Shyness: Practical Strategies for Adults
- Debunking the “Full Mood” Myth: Understanding Women’s Emotional Variability
- Coping with Sadness: Healthy Strategies for Emotional Well-being
